Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453225What this trial is testingEmpirical Radioactive Iodine Therapy in DTCWho this might be right forDifferentiated Thyroid Cancer Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT02432274What this trial is testingStudy of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With OsteosarcomaWho this might be right forTumorsSolid Malignant TumorsOsteosarcoma+1 more Eisai Limited 117
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848920What this trial is testingStudy of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid CarcinomaWho this might be right forDifferentiated Thyroid Carcinoma (DTC)Neoadjuvant Therapy Zhejiang University 20
Not applicableActive Not RecruitingNCT02185560What this trial is testingProspective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With SorafenibWho this might be right forThyroid Carcinoma Bayer 453
Testing effectiveness (Phase 2)Study completedNCT02614495What this trial is testingStudy of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid CarcinomaWho this might be right forThyroid Carcinoma Hutchison Medipharma Limited 66
Not applicableLooking for participantsNCT05510934What this trial is testingShared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.Who this might be right forLow Risk Differentiated Thyroid Cancer Nova Scotia Health Authority 60
Not applicableLooking for participantsNCT05024929What this trial is testingTargeted Therapy to Increase RAI Uptake in Metastatic DTCWho this might be right forPapillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer Children's Hospital of Philadelphia 32
Testing effectiveness (Phase 2)Looking for participantsNCT07092514What this trial is testingLenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)Who this might be right forThyroid CancerCancer of the Thyroid Washington University School of Medicine 34
Testing effectiveness (Phase 2)Looking for participantsNCT06359847What this trial is testingStudy of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Carcinoma Beijing Scitech-Mq Pharmaceuticals Limited 60
Not applicableNot Yet RecruitingNCT07536412What this trial is testingDecision Aid Efficacy in Low Risk Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer (DTC)Papillary Thyroid MicrocarcinomaPapillary Thyroid Carcinoma University of Maryland, Baltimore 34
Large-scale testing (Phase 3)Study completedNCT01321554What this trial is testingA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)Who this might be right forThyroid Cancer Eisai Inc. 392
Testing effectiveness (Phase 2)Study completedNCT02973997What this trial is testingLenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)Who this might be right forColumnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more Academic and Community Cancer Research United 57
Testing effectiveness (Phase 2)Study completedNCT02702388What this trial is testingA Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety ProfileWho this might be right forThyroid Cancer Eisai Inc. 241
Not applicableLooking for participantsNCT06405217What this trial is testingRecombinant Human Thyroid Stimulating Hormone for Radioiodine 131I TreatmentWho this might be right forDTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications Nanjing First Hospital, Nanjing Medical University 30
Early research (Phase 1)Looking for participantsNCT07287748What this trial is testingA Phase I Trial of Af-001 in Patients With Differentiated Thyroid CancerWho this might be right forDTC - Differentiated Thyroid Cancer Alpha Fusion Inc. 38
Not applicableStudy completedNCT03239769What this trial is testingCompare the Aesthetic Effect of Different ThyroidectomiesWho this might be right forDifferentiated Thyroid Carcinoma (DTC) Peking University Cancer Hospital & Institute 120
Not applicableStudy completedNCT07229859What this trial is testingRobotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound ScreeningWho this might be right forDifferentiated Thyroid Cancer (DTC)Robotic Assistance Ruijin Hospital 332
Not applicableUnknownNCT04858867What this trial is testingReinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)Who this might be right forDifferentiated Thyroid Cancer Leiden University Medical Center 12
Very early researchLooking for participantsNCT06898437What this trial is testingStudy of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid CancerWho this might be right forRadioiodine Refractory Differentiated Thyroid Cancer Peking Union Medical College Hospital 20
Not applicableLooking for participantsNCT06980103What this trial is testingUse of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid CancerWho this might be right forThyroid Cancer Georgetown University 408